Ki Cheol Park

An Orally Administered Multitarget Tyrosine Kinase Inhibitor, SU11248, Is a Novel Potent Inhibitor of Thyroid Oncogenic RET/Papillary Thyroid Cancer Kinases

Dong Wook Kim, Young Suk Jo, Hye Sook Jung et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 280 citations

Medicine, Oncology, Pharmacology +16

An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function.

Ju Hee Lee, Yea Eun Kang, Joon Young Chang et al. · PubMed · 2016 · 104 citations

Life Sciences, Endocrinology, Pharmacology +15

Statin inhibits interferon-γ-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells

Hyo Kyun Chung, In Kyu Lee, Hyokyung Kang et al. · Experimental & Molecular Medicine · 2002 · 95 citations · Full text

Life Sciences, Immunology, Pharmacology +17

The Atypical Orphan Nuclear Receptor DAX-1 Interacts with Orphan Nuclear Receptor Nur77 and Represses Its Transactivation

Kwang‐Hoon Song, Yun-Young Park, Ki Cheol Park et al. · Molecular Endocrinology · 2004 · 93 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

CR6-interacting Factor 1 Interacts with Gadd45 Family Proteins and Modulates the Cell Cycle

Hyo Kyun Chung, Yong Weon Yi, Neoncheol Jung et al. · Journal of Biological Chemistry · 2003 · 89 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12